Inicio › Colitis ulcerativa › Ohio
Ensayos clínicos de Colitis ulcerativa en Ohio
24 estudios sobre Colitis ulcerativa buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-025, Brunswick
- Site US-023, Dayton
- Site US-027, Westlake
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07845487Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Ohio State University, Hilliard
- DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro, Springboro
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Dayton Gastroenterology, LLC, Dayton
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07186101A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 3
Edades de 3 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06663332A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Great Lakes Gastroenterology Research, LLC, Mentor
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07577856ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Gastro Intestinal Research Institute of Northern Ohio,, Westlake
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 22 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT06810518Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Beavercreek
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 oct 2026 · NCT06619990A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Cincinnati, Cincinnati
- DSI Research Northridge LLC, Dayton
- Gastro Health Research - Liberty Township, Liberty Township
- y 3 más
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Dayton Gastroenterology - Beavercreek /ID# 284065, Beavercreek
- Gastro Intestinal Research Institute of Northern Ohio /ID# 283860, Westlake
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07697456A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- University Hospitals Cleveland Medical Center Rainbow Babies & Children's Hospital, Cleveland
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 2
Edades de 12 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT05287126A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University Hospitals Cleveland Medical Center /ID# 271831, Cleveland
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07071519An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of Cincinnati College of Medicine, Cincinnati
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
ReclutandoEstudio observacional
Edades de 18 a 64 · Todos los sexos · Actualizado el 26 oct 2026 · NCT06398626An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology & Hepatology Specialists, Inc. - Site Number: 8400139, Canton
- Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
- OSU Wexner Medical Center - Site Number: 8400077, Columbus
- y 4 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Cleveland Clinic, Cleveland
ReclutandoFase 2/3
Edades de 2 a 17 · Todos los sexos · Actualizado el 20 oct 2026 · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
- North Shore Gastroenterology Research - Site Number: 8400130, Westlake
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07185009Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of Cincinnati, Cincinnati
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06750731A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University Children's Clinic, Cleveland
- Cleveland Clinic, Cleveland
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06405087Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Cleveland Clinic Foundation, Cleveland
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07513181Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Cincinnati, Cincinnati
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
ReclutandoFase 3
Edades de 2 en adelante · Todos los sexos · Actualizado el 7 may 2026 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cincinnati
- Mirador Therapeutics Selected Site, Liberty Township
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522Evaluation of the SMART IBD App in Pediatric IBD
- Cincinnati Children's Hospital Medical Center, Cincinnati
Reclutando
Edades de 13 a 17 · Todos los sexos · Actualizado el 21 nov 2025 · NCT07195123De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.